DOCSLIB.ORG

Determinants of Archetype Bk Polyomavirus Replication

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

DETERMINANTS OF ARCHETYPE BK POLYOMAVIRUS REPLICATION by Nicole Marie Broekema A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Microbiology and Immunology) in The University of Michigan 2013 Doctoral Committee: Professor Michael J. Imperiale, Chair Professor Gregory R. Dressler Professor Katherine R. Spindler Associate Professor David Miller ACKNOWLEDGMENTS I want to thank my Ph.D. advisor, Dr. Michael Imperiale, first and foremost. Thank you for always taking time to listen to my ideas and constantly challenging me to be a better scientist. To my fellow labmates, especially Shauna Bennett and Dr. Mengxi Jiang: thank you for all the good times and advice about lab and life. I'm grateful for having such great people to share in my scientific journey. Also, I would like to thank Nico Conti for his help and enthusiasm on the model of archetype persistence in urothelial cells. I am grateful for my undergraduate and post-baccalaureate mentors: Dr. Robert Goodman, Dr. Mark Liles, Dr. Stacey Schultz-Cherry, Dr. David Warshauer, and Steve Marshall. It takes a village. Thank you for your patience and guidance. Thank you to all my committee members and other Microbiology and Immunology department faculty members for your time, advice, and guidance of my dissertation work. I want to thank Kathy Spindler. Christaine Wobus, Beth Moore, Billy Tsai, and members of the Imperiale laboratory for comments, discussion, and critical reading of manuscripts. Thanks to Amanda Pattridge and Dorothy Sorenson for technical assistance with TEM. We thank Richard Frisque for the pJC-CY plasmid and VP1 antibody, David Wang for the pBlu-KI and pBlu-WU plasmids and VP1 antibodies, Chris Sullivan and Gil Ju Seo for the miRNA luciferase reporter assay constructs and advice, and Hans Hirsch and Rainer Gosert for the phRG promoter construct. We thank Peter Gergics and the Sally Camper laboratory for use of their Promega GloMax 96 Microplate luminometer. ii This work would not have been possible without these funding sources: NIH grant AI060584 awarded to M.J.I and in part by NIH grant CA046592 awarded to the University of Michigan Cancer Center. N.M.B. was supported in part by the NIH National Research Service Award T32-GM07544 from the National Institute of General Medicine Sciences and a Rackham Predoctoral Fellowship from the University of Michigan. Finally, I am grateful for the love and support of friends and family, especially Jacob Notbohm and my parents. iii TABLE OF CONTENTS Acknowledgments ii List of Figures vi List of Tables viii Abstract ix Chapter I Introduction BK polyomavirus.............................................................................. 1 Viral persistence............................................................................... 3 Transmission and epidemiology....................................................... 5 Reactivation and clinical disease...................................................... 5 The intracellular viral lifecycle........................................................ 10 Archetype BKPyV............................................................................ 12 Host immune responses to BKPyV.................................................. 13 The polyomavirus miRNA............................................................... 16 Summary and chapter outline........................................................... 18 Notes................................................................................................ 19 References........................................................................................ 20 Chapter II A system for the analysis of BKPyV non-coding control regions: application to clinical isolates from an HIV/AIDS patient Abstract.................................. .......................................................... 27 Introduction...................................................................................... 27 Results.............................................................................................. 31 Discussion........................................................................................ 36 Materials and Methods..................................................................... 41 Notes................................................................................................ 45 References........................................................................................ 46 Chapter III Efficient propagation of archetype BK and JC polyomaviruses Abstract.................................. .......................................................... 50 Introduction...................................................................................... 50 Results.............................................................................................. 55 Discussion........................................................................................ 65 iv Materials and Methods..................................................................... 70 Notes................................................................................................ 74 References........................................................................................ 75 Chapter IV miRNA regulation of BK polyomavirus replication during early infection Abstract.................................. .......................................................... 79 Introduction...................................................................................... 79 Results.............................................................................................. 84 Discussion........................................................................................ 98 Materials and Methods..................................................................... 103 References........................................................................................ 110 Chapter V Discussion Chapter Summary............................................................................ 113 Future areas of study........................................................................ 120 Conclusions...................................................................................... 131 References........................................................................................ 135 Appendix Preliminary Studies of archetype virus persistence in urothelial cells Introduction...................................................................................... 140 Materials and Methods..................................................................... 143 Results and Discussion..................................................................... 144 References........................................................................................ 149 v List of Figures Figure 2.1 The NCCR determines replication efficiency of BKPyV........................................ 30 2.2 Schematic of the NCCRs.......................................................................................... 34 2.3 Clones isolated from a clinical specimen display variable replication abilities....... 35 2.4 The O block polymorphism does not affect replication ability................................ 37 3.1 TAg expression limits archetype BKPyV replication in RPTE cells....................... 56 3.2 Archetype BKPyV and JCPyV replicate efficiently in 293TT cells........................ 58 3.3 KI, WU, and MCPyV do not replicate efficiently in 293TT cells........................... 60 3.4 Archetype BKPyV and JCPyV produce infectious progeny in 293TT cells............ 62 3.5 Morphology of BKPyV produced in 293TT cells.................................................... 64 3.6 Purified archetype BKPyV is infectious in 293TT cells.......................................... 66 4.1 Schematic of the BKPyV genome............................................................................ 81 4.2 The BKPyV miRNA mutant is unable to regulate its target early mRNA............... 85 4.3 The wt Northern blot probe recognizes the mutant miRNA sequence..................... 87 4.4 Schematic of the miRNA stem-loop qPCR assay.................................................... 88 4.5 The BKPyV miRNA limits viral replication in RPTE cells..................................... 90 4.6 Promoter activity of archetype virus vs. rearranged variants................................... 93 4.7 Balance of promoter activity in archetype virus vs. rearranged variants................. 95 4.8 miRNA expression is partially regulated by sequences in the enhancer region....... 97 4.9 Model of miRNA control of archetype virus replication.......................................... 100 vi 5.1 Naturally occuring mutations in the BKPyV miRNA region................................... 128 5.2 Overview model of potential factors contributing to BKPyV persistence............... 132 A.1 Archetype virus DNA is maintained as an episome in urothelial cells..................... 146 A.2 Archetype virus DNA is specifically maintained as an episome in urothelial cells under selection.......................................................................................................... 147 vii List of Tables Tables 2.1 List of primers used for site-directed mutagenesis and SOE PCR........................... 42 4.1 List of primers used for cloning, site-directed mutagenesis, and real-time PCR...... 104 6.1 BK polyomavirus 5P miRNA [bkv-miR-B1-5p] predicted targets.........................
Recommended publications
  • Newly Discovered KI, WU, and Merkel Cell Polyomaviruses

    Newly Discovered KI, WU, and Merkel Cell Polyomaviruses

    Sadeghi et al. Virology Journal 2010, 7:251 http://www.virologyj.com/content/7/1/251 RESEARCH Open Access Newly discovered KI, WU, and Merkel cell polyomaviruses: No evidence of mother-to-fetus transmission Mohammadreza Sadeghi1, Anita Riipinen2, Elina Väisänen1, Tingting Chen1, Kalle Kantola1, Heljä-Marja Surcel3, Riitta Karikoski4, Helena Taskinen2,5, Maria Söderlund-Venermo1, Klaus Hedman1,6* Abstract Background: Three* human polyomaviruses have been discovered recently, KIPyV, WUPyV and MCPyV. These viruses appear to circulate ubiquitously; however, their clinical significance beyond Merkel cell carcinoma is almost completely unknown. In particular, nothing is known about their preponderance in vertical transmission. The aim of this study was to investigate the frequency of fetal infections by these viruses. We sought the three by PCR, and MCPyV also by real-time quantitative PCR (qPCR), from 535 fetal autopsy samples (heart, liver, placenta) from intrauterine fetal deaths (IUFDs) (N = 169), miscarriages (120) or induced abortions (246). We also measured the MCPyV IgG antibodies in the corresponding maternal sera (N = 462) mostly from the first trimester. Results: No sample showed KIPyV or WUPyV DNA. Interestingly, one placenta was reproducibly PCR positive for MCPyV. Among the 462 corresponding pregnant women, 212 (45.9%) were MCPyV IgG seropositive. Conclusions: Our data suggest that none of the three emerging polyomaviruses often cause miscarriages or IUFDs, nor are they transmitted to fetuses. Yet, more than half the expectant mothers were susceptible to infection by the MCPyV. Background tumorigenic MCPyV [5], also found in the nasopharynx Among the five* human polymaviruses known, aside [13-15], the mode of transmission and, host cells, as from the BK virus (BKV) and JC virus (JCV) [1,2], well as latency characteristics are yet to be established.
  • Identification of the Neutralizing Epitopes of Merkel Cell Polyomavirus Major Capsid Protein Within the BC and EF Surface Loops Maxime J J Fleury, Jérôme T.J

    Identification of the Neutralizing Epitopes of Merkel Cell Polyomavirus Major Capsid Protein Within the BC and EF Surface Loops Maxime J J Fleury, Jérôme T.J

    Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loops Maxime J J Fleury, Jérôme T.J. Nicol, Mahtab Samimi-Gharaei, Françoise Arnold, Raphael Cazal, Raphaelle Ballaire, Olivier Mercey, Hélène Gonneville, Nicolas Combelas, Jean-François Vautherot, et al. To cite this version: Maxime J J Fleury, Jérôme T.J. Nicol, Mahtab Samimi-Gharaei, Françoise Arnold, Raphael Cazal, et al.. Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loops. PLoS ONE, Public Library of Science, 2015, 10 (3), pp.1-13. 10.1371/journal.pone.0121751. hal-01190152 HAL Id: hal-01190152 https://hal.archives-ouvertes.fr/hal-01190152 Submitted on 1 Sep 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License RESEARCH ARTICLE Identification of the Neutralizing Epitopes of Merkel Cell Polyomavirus Major Capsid Protein within the BC and EF Surface Loops Maxime J. J. Fleury1,
  • Immunohistochemical Detection of KI Polyomavirus in Lung and Spleen

    Immunohistochemical Detection of KI Polyomavirus in Lung and Spleen

    Virology 468-470 (2014) 178–184 Contents lists available at ScienceDirect Virology journal homepage: www.elsevier.com/locate/yviro Immunohistochemical detection of KI polyomavirus in lung and spleen Erica A. Siebrasse 1,a, Nang L. Nguyen a,1, Colin Smith b, Peter Simmonds c, David Wang a,n a Washington University School of Medicine, Campus Box 8230, 660 S. Euclid Ave., St. Louis, MO 63110, USA b Department of Pathology, University of Edinburgh, Scotland, UK c Roslin Institute, University of Edinburgh, Scotland, UK article info abstract Article history: Little is known about the tissue tropism of KI polyomavirus (KIPyV), and there are no studies to date Received 23 April 2014 describing any specific cell types it infects. The limited knowledge of KIPyV tropism has hindered study of Returned to author for revisions this virus and understanding of its potential pathogenesis in humans. We describe tissues from two 28 July 2014 immunocompromised patients that stained positive for KIPyV antigen using a newly developed immuno- Accepted 5 August 2014 histochemical assay targeting the KIPyV VP1 (KVP1) capsid protein. In the first patient, a pediatric bone Available online 3 September 2014 marrow transplant recipient, KVP1 was detected in lung tissue. Double immunohistochemical staining Keywords: demonstrated that approximately 50% of the KVP1-positive cells were CD68-positive cells of the macro- KI polyomavirus phage/monocyte lineage. In the second case, an HIV-positive patient, KVP1 was detected in spleen and lung Tissue tropism tissues. These results provide the first identification of a specific cell type in which KVP1 can be detected and Immunohistochemistry expand our understanding of basic properties and in vivo tropism of KIPyV.
  • Antibodies Response to Polyomaviruses Primary Infection: High Seroprevalence of Merkel Cell

    Antibodies Response to Polyomaviruses Primary Infection: High Seroprevalence of Merkel Cell

    Antibodies response to Polyomaviruses primary infection: high seroprevalence of Merkel Cell Polyomavirus and lymphoid tissues involvement. Carolina Cason1, Lorenzo Monasta2, Nunzia Zanotta2, Giuseppina Campisciano2, Iva Maestri3, Massimo Tommasino4, Michael Pawlita5, Sonia Villani6, Manola Comar1,2, Serena Delbue6,*. Authors affiliations: 1 Department of Medical Sciences, University of Trieste, Piazzale Europa 1, 34127 Trieste, Italy. 2Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Via dell' Istria 65/1, 34137 Trieste, Italy. 3Department of Experimental and Diagnostic Medicine, Pathology Unit of Pathologic Anatomy, Histology and Cytology University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy. 4Infections and Cancer Biology Group, International Agency for Research on Cancer, Cours Albert Thomas 150, 69372 Lyon, France. 5German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. 6Department of Biomedical, Surgical & Dental Sciences, University of Milano, Via Pascal 36, 20100 Milano, Italy. * Corresponding author: [email protected], +390250315070 1 ABSTRACT Human polyomaviruses (HPyVs) asymptomatically infect the human population establishing latency in the host and their seroprevalence can reach 90% in healthy adults. Few studies have focused on the pediatric population and there are no reports regarding the seroprevalence of all the newly isolated HPyVs among Italian children. Therefore, we investigated the frequency of serum antibodies against 12 PyVs in 182 immunocompetent children from Northeast Italy, by means of a multiplex antibody detection system. Additionally, secondary lymphoid tissues were collected to analyze the presence of HPyVs DNA sequences using a specific Real Time PCRs or PCRs. Almost 100% of subjects were seropositive for at least one PyV. Seropositivity ranged from 3% for antibodies against Simian virus 40 (SV40) in children from 0 to 3 years, to 91% for antibodies against WU polyomavirus (WUPyV) and HPyV10 in children from 8 to 17 years.
  • Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups

    Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups

    microorganisms Communication Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups Carla Prezioso 1,2, Marijke Van Ghelue 3,4, Valeria Pietropaolo 1,* and Ugo Moens 5,* 1 Department of Public Health and Infectious Diseases, “Sapienza” University of Rome, 00185 Rome, Italy; [email protected] 2 IRCSS San Raffaele Pisana, Microbiology of Chronic Neuro-degenerative Pathologies, 00163 Rome, Italy 3 Department of Medical Genetics, Division of Child and Adolescent Health, University Hospital of North Norway, 9038 Tromsø, Norway; [email protected] 4 Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø—The Arctic University of Norway, 9037 Tromsø, Norway 5 Department of Medical Biology, Faculty of Health Sciences, University of Tromsø—The Arctic University of Norway, 9037 Tromsø, Norway * Correspondence: [email protected] (V.P.); [email protected] (U.M.) Abstract: Polyomaviruses infect many species, including humans. So far, 15 polyomaviruses have been described in humans, but it remains to be established whether all of these are genuine human polyomaviruses. The most recent polyomavirus to be detected in a person is Quebec polyomavirus (QPyV), which was identified in a metagenomic analysis of a stool sample from an 85-year-old hospitalized man. We used PCR to investigate the presence of QPyV DNA in urine samples from systemic lupus erythematosus (SLE) patients (67 patients; 135 samples), multiple sclerosis patients (n = 35), HIV-positive patients (n = 66) and pregnant women (n = 65). Moreover, cerebrospinal fluid from patients with suspected neurological diseases (n = 63), nasopharyngeal aspirates from patients Citation: Prezioso, C.; Van Ghelue, (n = 80) with respiratory symptoms and plasma samples from HIV-positive patients (n = 65) were M.; Pietropaolo, V.; Moens, U.
  • Advances in Human Polyomaviruses Field

    Advances in Human Polyomaviruses Field

    rren : Cu t R y es g e lo a o r r c i h V Virology: Current Research Ciotti, Virol Curr Res 2017, 1:1 Editorial Open Access Advances in Human Polyomaviruses Field Marco Ciotti* Laboratory of Molecular Virology, Polyclinic Tor Vergata Foundation, Viale Oxford 81, 00133 Rome, Italy *Corresponding author: Ciotti M, Laboratory of Molecular Virology, Polyclinic Tor Vergata Foundation, Viale Oxford 81, 00133 Rome, Italy, Tel: +390620902087; E-mail: [email protected] Received date: February 27, 2017; Accepted date: March 02, 2017; Published date: March 02, 2017 Copyright: © 2017 Ciotti M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Editorial References Polyomaviruses are small non-enveloped DNA viruses with a 1. Gardner SD, Field AM, Coleman DV, Hulme B (1971) New human circular double stranded genome of about 5 Kb in length. The genome papovavirus (B.K.) isolated from urine after renal transplantation. Lancet is contained in a capsid with icosahedral structure of about 45 nm in 1: 1253-1257. diameter. 2. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova-like virus from human brain with progressive Up to 2007, two human polyomaviruses BK (BKPyV) and JC multifocal leucoencephalopathy. Lancet 1: 1257-1260. (JCPyV) were known and named after the initials of the patients where 3. Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, et al. they were first isolated. BKV was isolated from the urine of a kidney (2007) Identification of a Third Human Polyomavirus.
  • Polyomavirus

    Polyomavirus

    GLOBAL WATER PATHOGEN PROJECT PART THREE. SPECIFIC EXCRETED PATHOGENS: ENVIRONMENTAL AND EPIDEMIOLOGY ASPECTS POLYOMAVIRUS Silvia Bofill-Mas University of Barcelona Barcelona, Spain Copyright: This publication is available in Open Access under the Attribution-ShareAlike 3.0 IGO (CC-BY-SA 3.0 IGO) license (http://creativecommons.org/licenses/by-sa/3.0/igo). By using the content of this publication, the users accept to be bound by the terms of use of the UNESCO Open Access Repository (http://www.unesco.org/openaccess/terms-use-ccbysa-en). Disclaimer: The designations employed and the presentation of material throughout this publication do not imply the expression of any opinion whatsoever on the part of UNESCO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The ideas and opinions expressed in this publication are those of the authors; they are not necessarily those of UNESCO and do not commit the Organization. Citation: Bofill-Mas, S. (2016). Polyomavirus. In: J.B. Rose and B. Jiménez-Cisneros, (eds) Water and Sanitation for the 21st Century: Health and Microbiological Aspects of Excreta and Wastewater Management (Global Water Pathogen Project). (J.S Meschke, and R. Girones (eds), Part 3: Specific Excreted Pathogens: Environmental and Epidemiology Aspects - Section 1: Viruses), Michigan State University, E. Lansing, MI, UNESCO. https://doi.org/10.14321/waterpathogens.16 Acknowledgements: K.R.L. Young, Project Design editor; Website Design: Agroknow (http://www.agroknow.com) Last published: August 12, 2016 Polyomavirus Summary HPyVs are not “classic” waterborne pathogens. Their presence in water environments is a relatively recent discovery and they are thus considered as emerging or Human Polyomaviruses (HPyVs) are small, non- potentially emerging waterborne pathogens.
  • Review Article Human Polyomavirus Reactivation: Disease Pathogenesis and Treatment Approaches

    Review Article Human Polyomavirus Reactivation: Disease Pathogenesis and Treatment Approaches

    Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2013, Article ID 373579, 27 pages http://dx.doi.org/10.1155/2013/373579 Review Article Human Polyomavirus Reactivation: Disease Pathogenesis and Treatment Approaches Cillian F. De Gascun1 and Michael J. Carr2 1 DepartmentofVirology,FrimleyParkHospital,Frimley,SurreyGU167UJ,UK 2 National Virus Reference Laboratory, University College Dublin, Belfield, Dublin 4, Ireland Correspondence should be addressed to Cillian F. De Gascun; [email protected] Received 4 February 2013; Revised 27 March 2013; Accepted 27 March 2013 Academic Editor: Mario Clerici Copyright © 2013 C. F. De Gascun and M. J. Carr. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. JC and BK polyomaviruses were discovered over 40 years ago and have become increasingly prevalent causes of morbidity and mortality in a variety of distinct, immunocompromised patient cohorts. The recent discoveries of eight new members of the Polyomaviridae family that are capable of infecting humans suggest that there are more to be discovered and raise the possibility that they may play a more significant role in human disease than previously understood. In spite of this, there remains a dearth of specific therapeutic options for human polyomavirus infections and an incomplete understanding of the relationship between the virus and the host immune system. This review summarises the human polyomaviruses with particular emphasis on pathogenesis in those directly implicated in disease aetiology and the therapeutic options available for treatment in the immunocompromised host. 1. Introduction were far more prevalent in the general population than the incidence of the diseases that they caused (PML and BKV- Polyomaviruses (PyV) are small (diameter 40–50 nm), associated nephropathy (BKVN), resp.) [12].
  • An Antibody Response to Human Polyomavirus 15-Mer Peptides Is Highly Abundant in Healthy Human Subjects

    An Antibody Response to Human Polyomavirus 15-Mer Peptides Is Highly Abundant in Healthy Human Subjects

    Stuyver et al. Virology Journal 2013, 10:192 http://www.virologyj.com/content/10/1/192 RESEARCH Open Access An antibody response to human polyomavirus 15-mer peptides is highly abundant in healthy human subjects Lieven J Stuyver1*, Tobias Verbeke2, Tom Van Loy1, Ellen Van Gulck3 and Luc Tritsmans4 Abstract Background: Human polyomaviruses (HPyV) infections cause mostly unapparent or mild primary infections, followed by lifelong nonpathogenic persistence. HPyV, and specifically JCPyV, are known to co-diverge with their host, implying a slow rate of viral evolution and a large timescale of virus/host co-existence. Recent bio-informatic reports showed a large level of peptide homology between JCPyV and the human proteome. In this study, the antibody response to PyV peptides is evaluated. Methods: The in-silico analysis of the HPyV proteome was followed by peptide microarray serology. A HPyV-peptide microarray containing 4,284 peptides was designed and covered 10 polyomavirus proteomes. Plasma samples from 49 healthy subjects were tested against these peptides. Results: In-silico analysis of all possible HPyV 5-mer amino acid sequences were compared to the human proteome, and 1,609 unique motifs are presented. Assuming a linear epitope being as small as a pentapeptide, on average 9.3% of the polyomavirus proteome is unique and could be recognized by the host as non-self. Small t Ag (stAg) contains a significantly higher percentage of unique pentapeptides. Experimental evidence for the presence of antibodies against HPyV 15-mer peptides in healthy subjects resulted in the following observations: i) antibody responses against stAg were significantly elevated, and against viral protein 2 (VP2) significantly reduced; and ii) there was a significant correlation between the increasing number of embedded unique HPyV penta-peptides and the increase in microarray fluorescent signal.
  • WU and KI Polyomavirus Infections in Pediatric Hematology/Oncology Patients

    WU and KI Polyomavirus Infections in Pediatric Hematology/Oncology Patients

    Journal of Clinical Virology 52 (2011) 28–32 Contents lists available at ScienceDirect Journal of Clinical Virology jo urnal homepage: www.elsevier.com/locate/jcv WU and KI polyomavirus infections in pediatric hematology/oncology patients with acute respiratory tract illness a,e c,f d,g b,∗ Suchitra Rao , Robert L. Garcea , Christine C. Robinson , Eric A.F. Simões a Department of Pediatrics, B158 The Children’s Hospital and University of Colorado School of Medicine, 13123 E 16th Ave, Aurora, CO 80045, United States b Department of Pediatrics, B055 The Children’s Hospital and University of Colorado School of Medicine, 13123 E 16th Ave, Aurora, CO 80045, United States c Department of Molecular, Cellular, and Developmental Biology, Porter Science Bldg. B249C, 347 UCB, University of Colorado Boulder, CO 80309-0347, United States d Department of Virology, B120, The Children’s Hospital and University of Colorado School of Medicine, 13123 E 16th Ave, Aurora, CO 80045, United States a r t i c l e i n f o a b s t r a c t Article history: Background: WU and KI polyomaviruses (PyV) were discovered in 2007 in respiratory tract samples Received 28 February 2011 in adults and children. Other polyomaviruses (BKPyV and JCPyV) have been associated with illness in Received in revised form 13 May 2011 immunocompromised patients, and some studies suggest a higher prevalence of WUPyV and KIPyV in Accepted 23 May 2011 this population. Objective: To determine whether a higher prevalence or viral load for WUPyV and KIPyV exists in immuno- Keywords: compromised children compared with immunocompetent children.
  • Common Exposure to STL Polyomavirus During Childhood Efrem S

    Common Exposure to STL Polyomavirus During Childhood Efrem S

    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 Common exposure to STL polyomavirus during childhood Efrem S. Lim Washington University School of Medicine in St. Louis Natalie M. Meinerz University of Colorado Boulder Blake Primi University of Colorado Boulder David Wang Washington University School of Medicine in St. Louis Robert L. Garcea University of Colorado Boulder Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Lim, Efrem S.; Meinerz, Natalie M.; Primi, Blake; Wang, David; and Garcea, Robert L., ,"Common exposure to STL polyomavirus during childhood." Emerging Infectious Diseases.20,9. 1559-61. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3541 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. persons ranges from 25% to 64%; all patients with Merkel Common cell carcinoma are seropositive (6,9). STLPyV was recently identified from fecal specimens Exposure to STL from a child in Malawi (10). Viral DNA also was detected in fecal specimens from the United States and The Gam- Polyomavirus bia, and STLPyV has been found in a surface-sanitized During Childhood skin wart surgically removed from the buttocks of a patient with a primary immunodeficiency called WHIM (warts, Efrem S. Lim, Natalie M. Meinerz, Blake Primi, hypogammaglobulinemia, infections, and myelokathexis) David Wang, and Robert L. Garcea syndrome (11). These observations suggest that STLPyV might infect humans. We defined the seropositivity rate of STL polyomavirus (STLPyV) was recently identified in STLPyV in humans using serum from 2 independent US human specimens.
  • Quantitative Detection of Human Malawi Polyomavirus in Nasopharyngeal Aspirates, Sera, and Feces in Beijing, China, Using Real-T

    Quantitative Detection of Human Malawi Polyomavirus in Nasopharyngeal Aspirates, Sera, and Feces in Beijing, China, Using Real-T

    Ma et al. Virology Journal (2017) 14:152 DOI 10.1186/s12985-017-0817-2 RESEARCH Open Access Quantitative detection of human Malawi polyomavirus in nasopharyngeal aspirates, sera, and feces in Beijing, China, using real- time TaqMan-based PCR Fen-lian Ma1, Dan-di Li1, Tian-li Wei2, Jin-song Li1 and Li-shu Zheng1* Abstract Background: Human Malawi polyomavirus (MWPyV) was discovered in 2012, but its prevalence and clinical characteristics are largely unknown. Methods: We used real-time TaqMan-based PCR to detect MWPyV in the feces (n = 174) of children with diarrhea, nasopharyngeal aspirates (n = 887) from children with respiratory infections, and sera (n = 200) from healthy adults, and analyzed its clinical characteristics statistically. All the MWPyV-positive specimens were also screened for other common respiratory viruses. Results: Sixteen specimens were positive for MWPyV, including 13 (1.47%) respiratory samples and three (1.7%) fecal samples. The samples were all co-infected with other respiratory viruses, most commonly with influenza viruses (69.2%) and human coronaviruses (30.7%). The MWPyV-positive children were diagnosed with bronchopneumonia or viral diarrhea. They ranged in age from 12 days to 9 years, and the most frequent symptoms were cough and fever. Conclusions: Real-time PCR is an effective tool for the detection of MWPyV in different types of samples. MWPyV infection mainly occurs in young children, and fecal–oral transmission is a possible route of its transmission. Keywords: Human Malawi polyomavirus (MWPyV), TaqMan real-time PCR, Nasopharyngeal aspirate, Feces, Respiratory virus Background (KIPyV and WUPyV), skin (MCPyV, HPyV6, HPyV7, The family Polyomaviridae contains small encapsidated and TSPyV), serum (HPyV9), stool samples (HPyV10 DNA viruses with a closed circular DNA genome of and isolates MW and MX, STLPyV), liver tissue ~5 kb, packaged within an icosahedral capsid structure.